Literature DB >> 33430369

Synergy, Additivity, and Antagonism between Cisplatin and Selected Coumarins in Human Melanoma Cells.

Paula Wróblewska-Łuczka1, Aneta Grabarska2, Magdalena Florek-Łuszczki3, Zbigniew Plewa4, Jarogniew J Łuszczki1.   

Abstract

(1) Cisplatin (CDDP) is used in melanoma chemotherapy, but it has many side effects. Hence, the search for natural substances that can reduce the dose of CDDP, and CDDP-related toxicity, is highly desired. Coumarins have many biological properties, including anticancer and antiproliferative effects. (2) An in vitro 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay on two human melanoma cell lines (FM55P and FM55M2) examined the antitumor properties of CDDP and five naturally occurring coumarins (osthole, xanthotoxin, xanthotoxol, isopimpinellin, and imperatorin). The antiproliferative effects produced by combinations of CDDP with the coumarins were assessed using type I isobolographic analysis. (3) The most potent anticancer properties of coumarins were presented by osthole and xanthotoxol. These compounds were characterized by the lowest median inhibitory concentration (IC50) values relative to the FM55P and FM55M2 melanoma cells. Isobolographic analysis showed that for both melanoma cell lines, the combination of CDDP and osthole exerted synergistic and additive interactions, while the combination of CDDP and xanthotoxol exerted additive interactions. Combinations of CDDP with xanthotoxin, isopimpinellin, and imperatorin showed antagonistic and additive interactions in two melanoma cell lines. (4) The combination of CDDP and osthole was characterized by the most desirable synergistic interaction. Isobolographic analysis allows the selection of potential candidates for cancer drugs among natural substances.

Entities:  

Keywords:  cisplatin; coumarins; drug interaction; melanoma

Year:  2021        PMID: 33430369     DOI: 10.3390/ijms22020537

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  6 in total

1.  Cannabidiol Interacts Antagonistically with Cisplatin and Additively with Mitoxantrone in Various Melanoma Cell Lines-An Isobolographic Analysis.

Authors:  Paweł Marzęda; Paula Wróblewska-Łuczka; Małgorzata Drozd; Magdalena Florek-Łuszczki; Katarzyna Załuska-Ogryzek; Jarogniew J Łuszczki
Journal:  Int J Mol Sci       Date:  2022-06-17       Impact factor: 6.208

2.  Imperatorin induces autophagy and G0/G1 phase arrest via PTEN-PI3K-AKT-mTOR/p21 signaling pathway in human osteosarcoma cells in vitro and in vivo.

Authors:  Minchao Lv; Qingxin Xu; Bei Zhang; Zhiqiang Yang; Jun Xie; Jinku Guo; Feixiong He; Wei Wang
Journal:  Cancer Cell Int       Date:  2021-12-19       Impact factor: 5.722

3.  Anticancer Activity of Amantadine and Evaluation of Its Interactions with Selected Cytostatics in Relation to Human Melanoma Cells.

Authors:  Danuta Krasowska; Agnieszka Gerkowicz; Paula Wróblewska-Łuczka; Aneta Grabarska; Katarzyna Załuska-Ogryzek; Dorota Krasowska; Jarogniew J Łuszczki
Journal:  Int J Mol Sci       Date:  2022-07-11       Impact factor: 6.208

Review 4.  Osthole: An up-to-date review of its anticancer potential and mechanisms of action.

Authors:  Shaojie Yang; Wanlin Dai; Jingnan Wang; Xiaolin Zhang; Yuting Zheng; Shiyuan Bi; Liwei Pang; Tengqi Ren; Ye Yang; Yang Sun; Zhuyuan Zheng; Shuodong Wu; Jing Kong
Journal:  Front Pharmacol       Date:  2022-09-07       Impact factor: 5.988

5.  Additive Interactions between Betulinic Acid and Two Taxanes in In Vitro Tests against Four Human Malignant Melanoma Cell Lines.

Authors:  Paula Wróblewska-Łuczka; Justyna Cabaj; Weronika Bąk; Julia Bargieł; Aneta Grabarska; Agnieszka Góralczyk; Jarogniew J Łuszczki
Journal:  Int J Mol Sci       Date:  2022-08-25       Impact factor: 6.208

6.  Sensitization of MCF7 Cells with High Notch1 Activity by Cisplatin and Histone Deacetylase Inhibitors Applied Together.

Authors:  Anna Wawruszak; Jarogniew Luszczki; Marta Halasa; Estera Okon; Sebastian Landor; Cecilia Sahlgren; Adolfo Rivero-Muller; Andrzej Stepulak
Journal:  Int J Mol Sci       Date:  2021-05-13       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.